National Taiwan University Hospital

Taipei, Taiwan ROC 10002

1 studies enrolling now · 3 studies all time

What they study most

Anemia, Carcinoma, Non-Small-Cell Lung, Cardiovascular Disease, Myelofibrosis

Studies at this site

• A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib — Recruiting now
• A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC — Running, not enrolling
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early